Use of recombinant gene delivery vectors for treating or preventing lysosomal storage disorders
AssigneesChiron Corporation, University of Iowa Research Foundation
InventorsBeverly Davidson, Douglas J. Jolly, Sybille L. Sauter, Colleen S. Stein, Thomas W. Dubensky, Jr., Jason A. Heth
Life of this patent
Estimating the term…
Abstract
Gene delivery vectors, for example, recombinant FIV vectors, and methods of using such vectors are provided for use in treating or preventing retinal diseases of the eye and diseases of the brain associated with lysosomal storage disorders.
Claims13
An FIV vector, comprising a 5′ FIV LTR, a tRNA binding site, a packaging signal, a promoter operably linked to a polynucleotide encoding a protein selected from the group consisting of β-glucuronidase, neuraminidase, sphingomyelinase, sulfatase, arylsulfatase β, α-neuraminidase, gangliosidase, tripeptidyl protease, CLN3, and palmitoyl protein thioesterase (PPT), an origin of second strand DNA synthesis and a 3′ FIV LTR, wherein the FIV vector is devoid of vif and ORF 2.
An FIV vector comprising a 5′ FIV LTR, a tRNA binding site, a packaging signal, a polynucleotide encoding β-glucuronidase operably linked to an FIV LTR promoter or a promoter element, an origin of second strand DNA synthesis and a 3′ FIV LTR, wherein the FIV vector is devoid of vif and ORF 2.
Dependencies are inferred from the claim text.